LAG3's Enigmatic Mechanism of Action

被引：127
作者：
Graydon, Colin G. [1 ]
Mohideen, Shifa [1 ]
Fowke, Keith R. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada
[2] Univ Nairobi, Dept Med Micobiol, Nairobi, Kenya
[3] Univ Manitoba, Max Rady Coll Med, Dept Community Hlth Sci, Winnipeg, MB, Canada
[4] Partners Hlth & Dev Africa, Nairobi, Kenya
来源：
FRONTIERS IN IMMUNOLOGY | 2021年 / 11卷
基金：
加拿大健康研究院;
关键词：
LAG3; immune checkpoint; immune exhaustion; checkpoint inhibition; mechanism of action; Lymphocyte activation gene-3; immune checkpoint inhibitors; LYMPHOCYTE-ACTIVATION GENE-3; NEGATIVE REGULATORY FUNCTION; T-CELL; TRANSCRIPTION FACTOR; LAG-3; CD223; EXPRESSION; PROTEIN; LIGAND; MOLECULES; PROLIFERATION;
D O I：
10.3389/fimmu.2020.615317
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
LAG3 is an important immune checkpoint with relevance in cancer, infectious disease and autoimmunity. However, despite LAG3's role in immune exhaustion and the great potential of LAG3 inhibition as treatment, much remains unknown about its biology, particularly its mechanism of action. This review describes the knowns, unknowns and controversies surrounding LAG3. This includes examination of how LAG3 is regulated transcriptionally and post-translationally by endocytosis and proteolytic cleavage. We also discuss the interactions of LAG3 with its ligands and the purpose thereof. Finally, we review LAG3's mechanism of action, including the roles of LAG3 intracellular motifs and the lack of a role for CD4 competition. Overall, understanding the biology of LAG3 can provide greater insight on LAG3 function, which may broaden the appreciation for LAG3's role in disease and potentially aid in the development of targeted therapies.
引用
收藏
页数：7
相关论文
共 57 条
  • [1] Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding
    Andrews, Lawrence P.
    Somasundaram, Ashwin
    Moskovitz, Jessica M.
    Szymczak-Workman, Andrea L.
    Liu, Chang
    Cillo, Anthony R.
    Lin, Huang
    Normolle, Daniel P.
    Moynihan, Kelly D.
    Taniuchi, Ichiro
    Irvine, Darrell J.
    Kirkwood, John M.
    Lipson, Evan J.
    Ferris, Robert L.
    Bruno, Tullia C.
    Workman, Creg J.
    Vignali, Dario A. A.
    [J]. SCIENCE IMMUNOLOGY, 2020, 5 (49)
  • [2] A LAG-3-Specific Agonist Antibody for the Treatment of T Cell-Induced Autoimmune Diseases
    Angin, Mathieu
    Brignone, Chrystelle
    Triebel, Frederic
    [J]. JOURNAL OF IMMUNOLOGY, 2020, 204 (04) : 810 - 818
  • [3] Opposite role for interleukin-4 and interferon-gamma on CD30 and lymphocyte activation gene-3 (LAG-3) expression by activated naive T cells
    Annunziato, F
    Manetti, R
    Cosmi, L
    Galli, G
    Heusser, CH
    Romagnani, S
    Maggi, E
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (09) : 2239 - 2244
  • [4] Initial efficacy of anti-lymphocyte activation gene-3 (anti-LAG-3; BMS-986016) in combination with nivolumab (nivo) in pts with melanoma (MEL) previously treated with anti-PD-1/PD-L1 therapy.
    Ascierto, Paolo Antonio
    Melero, Ignacio
    Bhatia, Shailender
    Bono, Petri
    Sanborn, Rachel E.
    Lipson, Evan J.
    Callahan, Margaret K.
    Gajewski, Thomas
    Gomez-Roca, Carlos A.
    Hodi, F. Stephen
    Curigliano, Giuseppe
    Nyakas, Marta
    Preusser, Matthias
    Koguchi, Yoshinobu
    Maurer, Matthew
    Clynes, Raphael
    Mitra, Priyam
    Suryawanshi, Satyendra
    Munoz-Couselo, Eva
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] CHARACTERIZATION OF THE LYMPHOCYTE-ACTIVATION GENE 3-ENCODED PROTEIN - A NEW LIGAND FOR HUMAN-LEUKOCYTE ANTIGEN CLASS-II ANTIGENS
    BAIXERAS, E
    HUARD, B
    MIOSSEC, C
    JITSUKAWA, S
    MARTIN, M
    HERCEND, T
    AUFFRAY, C
    TRIEBEL, F
    PIATIERTONNEAU, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (02) : 327 - 337
  • [6] Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV plus Aging
    Belkina, Anna C.
    Starchenko, Alina
    Drake, Katherine A.
    Proctor, Elizabeth A.
    Pihl, Riley M. F.
    Olson, Alex
    Lauffenburger, Douglas A.
    Lin, Nina
    Snyder-Cappione, Jennifer E.
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [7] Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class II
    Bruniquel, D
    Borie, N
    Hannier, S
    Triebel, F
    [J]. IMMUNOGENETICS, 1998, 48 (02) : 116 - 124
  • [8] LAG-3 (CD223) reduces macrophage and dendritic cell differentiation from monocyte precursors
    Buisson, S
    Triebel, F
    [J]. IMMUNOLOGY, 2005, 114 (03) : 369 - 374
  • [9] Proliferation of activated CD1d-restricted NKT cells is down-modulated by lymphocyte activation gene-3 signaling via cell cycle arrest in S phase
    Byun, Hyun-Jung
    Jung, Woon-Won
    Lee, Dong-Sup
    Kim, Sanghee
    Kim, Sang Joon
    Park, Chung-Gyu
    Chung, Hee Yong
    Chun, Taehoon
    [J]. CELL BIOLOGY INTERNATIONAL, 2007, 31 (03) : 257 - 262
  • [10] Alternative Activation of Human Plasmacytoid DCs In Vitro and in Melanoma Lesions: Involvement of LAG-3
    Camisaschi, Chiara
    De Filippo, Annamaria
    Beretta, Valeria
    Vergani, Barbara
    Villa, Antonello
    Vergani, Elisabetta
    Santinami, Mario
    Cabras, Antonello Domenico
    Arienti, Flavio
    Triebel, Frederic
    Rodolfo, Monica
    Rivoltini, Licia
    Castelli, Chiara
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (07) : 1893 - 1902
123456